How PT Genero Pharmaceuticals Secured Reliable, Cost-Optimized Cloud Infrastructure with AWS and ICS Compute Managed Service

Executive Summary

PT Genero Pharmaceuticals, a leading innovator in Indonesia’s pharmaceutical sector, needed to modernize its digital backbone to support research, regulatory compliance, and nationwide distribution. With sensitive drug development data and patient-related clinical trial records at stake, Genero required a secure, scalable, and cost-efficient cloud infrastructure.

Instead of building an expensive 24/7 internal IT and security team, Genero partnered with PT. Innovation Cloud Services (ICS Compute), an AWS Premier Partner. ICS operates as a next-generation Managed Service Provider (MSP) with Managed Security Service capabilities embedded directly into its offering. This unified model ensures Genero’s AWS infrastructure is continuously monitored, hardened against cyber threats, optimized for cost efficiency, and resilient enough to support mission-critical pharmaceutical operations.

About PT Genero Pharmaceuticals

Genero Pharmaceuticals is a trusted name in Indonesia’s healthcare and pharmaceutical industry, known for its commitment to innovation, compliance, and patient safety. With operations spanning R&D, clinical trials, and nationwide distribution, Genero relies heavily on digital systems to manage sensitive data, streamline supply chains, and ensure regulatory adherence.

For Genero, technology is not just an enabler, it is a compliance requirement. Whether accessing clinical trial data, submitting reports to regulators, or ensuring uninterrupted distribution of essential medicines, reliability and security are non-negotiable.

The Challenge

As Genero expanded digitally, four critical challenges emerged:

About PT. Innovation Cloud Services (ICS Compute)

ICS Compute is an AWS Premier Partner trusted by hundreds of organizations to operate cloud infrastructure with discipline and foresight. Specializing exclusively in AWS environments, ICS delivers operational excellence through competencies in Security Consulting, Migration & Modernization, Resilience, GenAI, and DevOps.

ICS Compute’s Managed Service model integrates Managed Security Service functions, ensuring that operations and security are inseparable. This approach provides Genero with operational peace of mind, allowing leadership to focus on pharmaceutical innovation while ICS ensures the foundation is secure, cost-efficient, and resilient.

The Solution

ICS designed a partnership model aligned with Genero’s business rhythm and compliance needs:

Results and Benefits

Business Outcome How It Was Achieved
IT Team Refocused on Innovation Offloading 24/7 monitoring, patching, and security operations freed Genero’s IT team to focus on digital pharma solutions and R&D innovation.
Predictable Cloud Economics Daily optimization transformed cloud spend into a forecastable cost, improving budget accuracy for finance leadership.
Strengthened Data Security & Compliance Continuous security reviews and rapid patch deployment safeguarded sensitive pharmaceutical data, reinforcing compliance with healthcare regulations.
Operational Reliability 24/7 coverage eliminated downtime risks, ensuring uninterrupted clinical trial systems and medicine distribution.
Strategic Confidence With a professionally managed foundation, Genero leadership accelerated its digital roadmap, confident that infrastructure could scale securely with business growth.

The Bottom Line

For PT Genero Pharmaceuticals, partnering with ICS Compute was a strategic decision to secure sensitive data, optimize cloud costs, and ensure operational reliability. By entrusting infrastructure operations to AWS specialists, Genero empowered its internal team to focus on pharmaceutical innovation and patient safety.

When digital reliability becomes invisible because it simply works, pharmaceutical leaders can focus on what truly matters: delivering safe, effective medicines to the people who need them most.